1. Treatment of osteoporosis (1) To reduce the incidence of fractures (hip, vertebral and non-vertebral osteoporosis-related fractures) (2) To reduces the incidence of new clinical fractures in patients at high risk of fracture, defined as a recent low-trauma hip fracture (3) to increase bone mass in men with osteoporosis 2. Treatment and prevention of postmenopausal osteoporosis 3. Treatment and prevention of glucocorticoid-induced osteoporosis 4. Treatment of Paget’s disease of bone

Once a year, as an intravenous infucion over no less than 15 minutes

Sealed container, room temperature(1~30℃)

1 bottle (100mL/bottle)